Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro. [electronic resource]
Producer: 20130503Description: 5364-73 p. digitalISSN:- 1557-3265
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Apoptosis -- drug effects
- Ataxia Telangiectasia Mutated Proteins
- Cell Cycle Checkpoints -- drug effects
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Checkpoint Kinase 1
- Cytarabine -- administration & dosage
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Protein Kinase Inhibitors -- administration & dosage
- Protein Kinases -- metabolism
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.